New 'hidden' coronavirus gene identified, could help in developing vaccine

knowing more about the 15 genes that make up the coronavirus genome could have a significant impact on developing drugs and vaccines to combat the virus

Coronavirus, covid, tests
The research team identified a new overlapping gene -- ORF3d -- in the novel coronavirus SARS-CoV-2 that has the potential to encode a protein that is longer than expected.
Press Trust of India New York
3 min read Last Updated : Nov 11 2020 | 11:33 AM IST

Researchers have discovered a new "hidden" gene in the novel coronavirus which may contribute to its unique biology and pandemic potential, an advance that may lead to the development of new therapeutics against the deadly virus.

According to the scientists, including those from the American Museum of Natural History in the US, knowing more about the 15 genes that make up the coronavirus genome could have a significant impact on developing drugs and vaccines to combat the virus.

In the current study, published in the journal eLife, the researchers described overlapping genes -- or "genes within genes" -- in the virus which they believe play a role in the replication of the virus within host cells.

"Overlapping genes may be one of an arsenal of ways in which coronaviruses have evolved to replicate efficiently, thwart host immunity, or get themselves transmitted," said study lead author Chase Nelson from the American Museum of Natural History.

"Knowing that overlapping genes exist and how they function may reveal new avenues for coronavirus control, for example through antiviral drugs," Nelson added.

The research team identified a new overlapping gene -- ORF3d -- in the novel coronavirus SARS-CoV-2 that has the potential to encode a protein that is longer than expected.

They said ORF3d is also present in a previously discovered pangolin coronavirus, indicating the gene may have undergone changes during the evolution of SARS-CoV-2 and related viruses.

According to the study, ORF3d has been independently identified and shown to elicit a strong antibody response in COVID-19 patients, demonstrating that the protein produced from the new gene is manufactured during human infection.

"We don't yet know its function or if there's clinical significance. But we predict this gene is relatively unlikely to be detected by a T-cell response, in contrast to the antibody response. And maybe that has something to do with how the gene was able to arise," Nelson said.

The scientists explained that genes in coronaviruses can seem like written language in that they are made of strings of chemical base molecules Adenine, Guanine, Uracil and Cytosine, represented by the letters A, G, U and C respectively.

They explained that these letters act as an information code for the synthesis of proteins within cells.

But while the units of language (words) are discrete and non-overlapping, the researchers said genes can be overlapping and multi-functional, with information cryptically encoded depending on where you start "reading."

While overlapping genes are hard to spot, and most scientific computer programs are not designed to find them, the scientists said they are common in viruses.

This is partly because RNA viruses have a high mutation rate, so they tend to keep their gene count low to prevent a large number of mutations, they explained.

The researchers noted that viruses have evolved a "sort of data compression system" in which one letter in its genome can contribute to two or even three different genes.

"Missing overlapping genes puts us in peril of overlooking important aspects of viral biology," said Nelson.

"In terms of genome size, SARS-CoV-2 and its relatives are among the longest RNA viruses that exist. They are thus perhaps more prone to 'genomic trickery' than other RNA viruses," he added.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :CoronavirusCoronavirus TestsCoronavirus VaccineHealth Ministry

First Published: Nov 11 2020 | 11:25 AM IST

Next Story